Abstract
In December 2019, the emerging of a new coronavirus-induced pneumonia created a distress among people in China and the international community. This virus was identified as novel coronavirus 2019-nCoV. At the time this Review went to press, the virus has spread to across 27 countries, infecting 17,488 people and caused 362 deaths. The transmission of 2019-nCoV to individuals of different countries is predominantly through close contact with an infected person. Based on the available data, there is a rising trend of infected and death cases. At this point, there is no specific drug or vaccine to treat infected patients besides supportive care. Nevertheless, researchers and doctors around the world have reported the success of using existing antiviral drugs to treat patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
